Expert Review of Molecular Diagnostics

Papers
(The H4-Index of Expert Review of Molecular Diagnostics is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-09-01 to 2024-09-01.)
ArticleCitations
LAMP Diagnostics at the Point-of-Care: Emerging Trends and Perspectives for the Developer Community139
The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery44
Advances in tests for colorectal cancer screening and diagnosis43
The diagnostic methods in the COVID-19 pandemic, today and in the future42
Rapid lateral flow tests for the detection of SARS-CoV-2 neutralizing antibodies42
The diagnostic and prognostic role of neutrophil-to-lymphocyte ratio in COVID-19: a systematic review and meta-analysis40
Noninvasive detection of COPD and Lung Cancer through breath analysis using MOS Sensor array based e-nose36
Critical insight into recombinase polymerase amplification technology35
Role of N6-methyladenosine modification in pathogenesis of ischemic stroke32
Developing multiplex ddPCR assays for SARS-CoV-2 detection based on probe mix and amplitude based multiplexing32
Diagnosis for COVID-19: current status and future prospects31
Enzymatic cross-linking of collagens in organ fibrosis – resolution and assessment25
Emerging circulating MiRNAs and LncRNAs in upper gastrointestinal cancers25
Ultrasensitive circulating tumor DNA analysis enables precision medicine: experimental workflow considerations24
Predictive biomarkers of response to immune checkpoint inhibitors in hepatocellular carcinoma23
Nanomaterial-based Optical and Electrochemical Biosensors for Amyloid beta and Tau: Potential for early diagnosis of Alzheimer’s Disease22
A review on current diagnostic techniques for COVID-1922
Metabolomics-based predictive biomarkers of radiation injury and countermeasure efficacy: current status and future perspectives22
Blood-based traumatic brain injury biomarkers – Clinical utilities and regulatory pathways in the United States, Europe and Canada22
Antimicrobial resistance prediction in Neisseria gonorrhoeae: current status and future prospects22
Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome22
Saliva as a sample type for SARS-CoV-2 detection: implementation successes and opportunities around the globe22
Aptamer-based sensing of breast cancer biomarkers: a comprehensive review of analytical figures of merit22
Liquid biopsy from research to clinical practice: focus on non-small cell lung cancer22
Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes22
0.054289102554321